ACM
NBRV
Aisling Capital Management’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-90,000
| Closed | -$16K | – | 19 |
|
|
2022
Q2 | $16K | Sell |
90,000
-101,028
| -53% | -$18K | 0.01% | 19 |
|
|
2022
Q1 | $80K | Hold |
191,028
| – | – | 0.04% | 21 |
|
|
2021
Q4 | $114K | Hold |
191,028
| – | – | 0.04% | 21 |
|
|
2021
Q3 | $227K | Hold |
191,028
| – | – | 0.05% | 21 |
|
|
2021
Q2 | $258K | Hold |
191,028
| – | – | 0.04% | 21 |
|
|
2021
Q1 | $317K | Hold |
191,028
| – | – | 0.06% | 15 |
|
|
2020
Q4 | $462K | Sell |
191,028
-1,719,259
| -90% | -$4.16M | 0.08% | 16 |
|
|
2020
Q3 | $1.02M | Hold |
1,910,287
| – | – | 0.33% | 15 |
|
|
2020
Q2 | $1.29M | Hold |
1,910,287
| – | – | 0.49% | 12 |
|
|
2020
Q1 | $1.1M | Hold |
1,910,287
| – | – | 0.48% | 13 |
|
|
2019
Q4 | $2.52M | Hold |
1,910,287
| – | – | 0.97% | 12 |
|
|
2019
Q3 | $3.82M | Buy |
1,910,287
+101,028
| +6% | +$202K | 1.99% | 9 |
|
|
2019
Q2 | $4.4M | Hold |
1,809,259
| – | – | 1.88% | 11 |
|
|
2019
Q1 | $4.42M | Hold |
1,809,259
| – | – | 3.36% | 9 |
|
|
2018
Q4 | $2.64M | Buy |
+1,809,259
| New | +$2.64M | 2.78% | 11 |
|